Gilead Sciences donates 5,000 remdesivir vials for emergency use amid the Marburg virus outbreak in Rwanda, as the country plans clinical trials for new treatments. Â
Gilead Sciences donates 5,000 remdesivir vials for emergency use amid the Marburg virus outbreak in Rwanda, as the country plans clinical trials for new treatments. Â
The African Spectator stands as the compass for those seeking lucid, objective, and insightful commentary on Africa’s ever-evolving political and social landscape.
© 2024 The African Spectator. All Rights Reserved.